About Company
Mitsubishi Tanabe Pharma America (MTPA) is a leading biopharmaceutical company committed to improving the health and well-being of patients by advancing innovative therapies. A subsidiary of Mitsubishi Tanabe Pharma Corporation, MTPA focuses on the development and commercialization of specialized medicines in areas such as neurology, immunology, and rare diseases. With a patient-centric approach, MTPA works closely with healthcare professionals to bring cutting-edge treatments to market. The company strives to enhance the quality of life for patients while fostering a culture of scientific excellence and ethical responsibility.